Multiple sclerosis (MS), in which demyelination of the central nervous system (CNS) is a hallmark characteristic, is generally considered to be an autoimmune disease. However, neither the cause of MS nor triggers for developing the disease are well understood.

Charles River conducts contract studies in established animal models of MS to test the efficacy of novel therapeutics:

We have answered some frequently asked questions about our MS models.